Rani Therapeutics Holdings, Inc. Share Price
Stocks
RANI
US7530181004
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8509 USD | -4.39% |
|
+22.03% | -36.97% |
| 07-15 | Rani Therapeutics Reports Positive Initial Phase 1A Data for Rt-114 for the Treatment of Obesity | CI |
| 07-15 | Rani Therapeutics Reports Positive Initial Phase 1a Data for RT-114 in Obesity | MT |
| Market Cap | 85.02M 74.67M 69.44M 63.72M 120M 8.19B 122M 825M 322M 4.03B 319M 312M 13.92B | P/E 2026 * |
-4.64x | P/E 2027 * | -3.99x |
|---|---|---|---|---|---|
| Enterprise Value | 85.02M 74.67M 69.44M 63.72M 120M 8.19B 122M 825M 322M 4.03B 319M 312M 13.92B | EV / Sales 2026 * |
20.6x | EV / Sales 2027 * | 17.3x |
| Free-Float |
78.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Rani Therapeutics Holdings, Inc.
| 1 day | -4.39% | ||
| 1 week | +22.03% | ||
| Current month | +11.90% | ||
| 1 month | +15.63% | ||
| 3 months | -9.37% | ||
| 6 months | -38.34% | ||
| Current year | -36.97% |
| 1 week | 0.64 |  | 0.95 |
| 1 month | 0.61 | | 0.95 |
| Current year | 0.61 | | 1.54 |
| 1 year | 0.44 | | 3.87 |
| 3 years | 0.39 | | 8.75 |
| 5 years | 0.39 | | 36.27 |
| 10 years | 0.39 | | 36.27 |
| Manager | Title | Age | Since |
|---|---|---|---|
Talat Imran
CEO | Chief Executive Officer | 45 | 31/05/2021 |
Nicholas Maestas
DFI | Director of Finance/CFO | 46 | 28/06/2026 |
Alireza Javadi
CTO | Chief Tech/Sci/R&D Officer | 42 | 31/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Mir Imran
CHM | Chairman | 69 | 31/05/2021 |
Dennis Ausiello
BRD | Director/Board Member | 80 | 31/08/2018 |
Jean-Luc Butel
BRD | Director/Board Member | 69 | 05/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 21/07/26 | In-Cube, Inc.
| Other | Company | 0 | 0% | |
| 21/07/26 | In-Cube, Inc.
| Other | Company | 0 | 0% | |
| 21/07/26 | Buy | Founder | 36,000 | 0.0361% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.39% | +22.03% | +59.94% | -80.17% | 85.02M | |
| -0.25% | +6.26% | +56.47% | +70.71% | 57.28B | |
| -1.92% | +6.03% | +40.64% | +80.66% | 54.99B | |
| -0.46% | -1.29% | +2.86% | +425.15% | 23.18B | |
| -2.97% | -2.35% | -22.53% | -15.34% | 22.59B | |
| -0.61% | +1.57% | +21.44% | -7.26% | 20.46B | |
| +0.51% | +2.33% | +26.21% | -29.74% | 17.56B | |
| 0.00% | +2.18% | +34.82% | +547.80% | 15.67B | |
| -1.30% | -5.02% | +170.77% | +310.94% | 14.46B | |
| -0.50% | -0.98% | +21.43% | +179.36% | 13.92B | |
| Average | -1.20% | +3.35% | +41.20% | +148.21% | 24.02B | |
| Weighted average by Cap. | -0.99% | +2.10% | +38.49% | +136.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.13M 3.63M 3.37M 3.09M 5.81M 397M 5.9M 40.03M 15.64M 195M 15.49M 15.16M 676M | 4.92M 4.33M 4.02M 3.69M 6.94M 474M 7.04M 47.77M 18.66M 233M 18.49M 18.09M 806M |
| Net income | -34.36M -30.18M -28.06M -25.75M -48.39M -3.31B -49.13M -333M -130M -1.63B -129M -126M -5.62B | -39.93M -35.07M -32.61M -29.93M -56.23M -3.85B -57.1M -387M -151M -1.89B -150M -147M -6.54B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | US$0.8509 | -4.39% | 1,443,479 |
| 23/07/26 | US$0.8900 | -0.75% | 1,435,194 |
| 22/07/26 | US$0.8967 | +29.77% | 6,333,087 |
| 21/07/26 | US$0.6910 | +0.68% | 591,064 |
| 20/07/26 | US$0.6863 | -1.58% | 393,888 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RANI Stock
Select your edition
All financial news and data tailored to specific country editions
